Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Comment by PeterGon Jan 30, 2024 3:33pm
105 Views
Post# 35853385

RE:RE:RE:RE:RE:RE:ANTICIPATED PRODUCT LINE PRESS RELEASE

RE:RE:RE:RE:RE:RE:ANTICIPATED PRODUCT LINE PRESS RELEASECome on! Remember mid of 2022 right after the Allergan deal was announced, they promised a fundamental change of the company with clear visibility and ongoing updates to shareholders. I think you know what happened!! Howard's best friends from PRC Partners tried to push the share price as well but that was only hot air!! I remain pessimistic  until clear trigger points achieved : Knowing who is the team of experts guiding Sirona laboratories and secondly who are the investors or hedge fonds who will invest and how this will happen?? And if these experts again are members from Family Hopton or Verrico, then we are all lost!!
<< Previous
Bullboard Posts
Next >>